Merck & Co

LITESPARK-011 trial meets primary endpoint of progression-free survival in patients previously treated with anti-PD-1/L1 therapy

GlobalData attributes this drop to price competition from local manufacturers and China’s ongoing anti-corruption crackdown on the…

GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…

Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing…

Major acquisitions and venture capital investments signal continued activity despite decline in overall deal value

2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry

Mergers and acquisitions in the healthcare sector experience a significant decline, while venture capital investments also see a…

Market cap surged from $3.49 trillion during the first quarter (Q1) of 2023 to $3.56 trillion in Q2 2023

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

The companies said in a statement they would uphold the integrity of the scientific process as they work towards potential global…